Literature DB >> 7613530

A health-related quality of life measure for multiple sclerosis.

B G Vickrey1, R D Hays, R Harooni, L W Myers, G W Ellison.   

Abstract

The need for measures of health-related quality of life (HRQOL) for clinical effectiveness research and for quality of care research, particularly for chronic diseases, is increasingly recognized. We assessed a measure of HRQOL for people with multiple sclerosis, a chronic neurological condition. We used the RAND 36-Item Health Survey 1.0 (aka SF-36) as a generic core measure, to enable comparisons of HRQOL of patients with multiple sclerosis to those of other patient populations and to the general population. To enhance comparisons within groups of multiple sclerosis patients, these items were supplemented with 18 additional items in the areas of health distress (four items), sexual function (four items), satisfaction with sexual function (one item), overall quality of life (two items), cognitive function (four items), energy (one item), pain (one item), and social function (one item). The final measure, the Multiple Sclerosis Quality of Life (MSQOL)-54 Instrument, contains 52 items distributed into 12 scales, and two single items. Internal consistency reliability estimates for the 12 multi-item scales ranged from 0.75 to 0.96 in a sample of 179 patients with multiple sclerosis. Test-retest intraclass correlation coefficients ranged from 0.66 to 0.96. Exploratory factor analysis confirmed two underlying dimensions of physical health and mental health. Construct validity was supported by significant associates between MSQOL-54 scales and degree of multiple sclerosis symptom severity in the prior year, level of ambulation, employment limitations due to health, admission to hospital in the previous year, and depressive symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 7613530     DOI: 10.1007/BF02260859

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  30 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

3.  The Functional Status Questionnaire: reliability and validity when used in primary care.

Authors:  A M Jette; A R Davies; P D Cleary; D R Calkins; L V Rubenstein; A Fink; J Kosecoff; R T Young; R H Brook; T L Delbanco
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

Review 4.  Symptom management in multiple sclerosis.

Authors:  R T Schapiro
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

5.  Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

Authors:  M H Liang; M G Larson; K E Cullen; J A Schwartz
Journal:  Arthritis Rheum       Date:  1985-05

6.  A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota.

Authors:  D R Wynn; M Rodriguez; W M O'Fallon; L T Kurland
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

Review 7.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

8.  Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts.

Authors:  W E Cunningham; S A Bozzette; R D Hays; D E Kanouse; M F Shapiro
Journal:  Med Care       Date:  1995-04       Impact factor: 2.983

9.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

10.  Development of the quality of life in epilepsy inventory.

Authors:  O Devinsky; B G Vickrey; J Cramer; K Perrine; B Hermann; K Meador; R D Hays
Journal:  Epilepsia       Date:  1995-11       Impact factor: 5.864

View more
  242 in total

1.  Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life.

Authors:  D Parkin; A Jacoby; P McNamee; P Miller; S Thomas; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

Review 2.  Quality of life and neurological illness: a review of the literature.

Authors:  R Murrell
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

Review 3.  Statins for multiple sclerosis.

Authors:  Jin Wang; Yousheng Xiao; Man Luo; Hongye Luo
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

4.  Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Authors:  Francesco Patti; Maria Pia Amato; Maria Trojano; Stefano Bastianello; Maria Rosalia Tola; Orietta Picconi; Sabina Cilia; Salvatore Cottone; Luigi M E Grimaldi
Journal:  Qual Life Res       Date:  2011-09-28       Impact factor: 4.147

5.  Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.

Authors:  Peter J Jongen; Dirk Lehnick; Evert Sanders; Pierette Seeldrayers; Sten Fredrikson; Magnus Andersson; Joachim Speck
Journal:  Health Qual Life Outcomes       Date:  2010-11-15       Impact factor: 3.186

6.  Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Authors:  Stefan M Gold; Kyle C Kern; Mary-Frances O'Connor; Michael J Montag; Aileen Kim; Ye S Yoo; Barbara S Giesser; Nancy L Sicotte
Journal:  Biol Psychiatry       Date:  2010-06-19       Impact factor: 13.382

7.  Factors associated with health-related quality of life among older people with multiple sclerosis.

Authors:  Marijean Buhse; Wendy M Banker; Lynn M Clement
Journal:  Int J MS Care       Date:  2014

8.  Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis.

Authors:  R B Forbes; A Lees; N Waugh; R J Swingler
Journal:  BMJ       Date:  1999-12-11

9.  Assessing the gap between current movement ability and preferred movement ability as a measure of disability.

Authors:  Diane D Allen; Joanne M Wagner
Journal:  Phys Ther       Date:  2011-10-14

10.  Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

Authors:  Margaret M Schmitt; Yael Goverover; John Deluca; Nancy Chiaravalloti
Journal:  Rehabil Psychol       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.